Division News

The Department of Medicine (DOM) is creating a taskforce charged with developing the internal medicine component of a new program called outPatient Integrated lONgitudinal ExpERience, or PIONEER, for second-year medical students.

The goal of PIONEER is to increase their experience with the outpatient practice of general internal medicine and its subspecialties, as well as increase opportunities for faculty to teach medical students in the clinic setting.

The Duke Internal Medicine Residency Program and the Duke Department of Medicine congratulate newly matched medical students who participated in the 2022 National Resident Matching Program.  We are especially excited to welcome our newest intern class! We cannot wait for you to join us here in Durham.

By Steve Hartsoe

Thousands of COVID-19 survivors continue to grapple with symptoms many months after they were first infected. Brain fog, fatigue, even sexual dysfunction are among the symptoms people endure weeks and months after their acute COVID symptoms fade.

On some occasions, the virus reveals a pre-existing disease or causes another to inflict the patient.

But there is still much unknown about so-called long COVID, which ongoing research at Duke University and elsewhere aims to clarify.

Steve M. Taylor, MD, MPH, associate professor of medicine, Division of Infectious Diseases, and associate research professor of global health, is taking on the new position of Associate Vice Chair for Global Health Research in the Department of Medicine effective March 1, 2022.

Web and phone-based enrollment allows people to help test potential COVID-19 treatments without leaving home

DURHAM, N.C. – A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate ivermectin at a higher dose for a longer period of time.

Robert M. Califf, MD, Duke University adjunct professor of medicine (cardiology) and former director of the Duke Clinical Research Institute (DCRI), has been confirmed as commissioner for the U.S. Food and Drug Administration following a vote by the Senate today. Califf’s appointment to the position will mark his second time heading the agency, which he also led during the final year of former President Barack Obama’s administration.

Duke University School of Medicine was awarded more than $608 million in federal funding from the National Institutes of Health (NIH) in 2021, ranking third nationally among academic medical centers, up from 10th last year, according to the Blue Ridge Institute for Medical Research.

The Department of Medicine's award of that total was $174,530,472. 

Sponsored Research

Andrew Armstrong of Medical Oncology has received an award from the Movember Foundation for a project entitled "International Retrospective Collaborative Analysis of the Impact of Ablative Therapy Directed to the Local Tumor and/or Metastases for Patients with Oligometastatic Prostate Cancer¿." TBD

Vance Fowler of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "HLA Fine Mapping to Elucidate S. aureus Susceptibility - R01." Total funding will be $3,757,863.

Congratulations to the following faculty members for their recent promotion in the Department of Medicine. The following changes were approved during the August 20, 2021, and September 24, 2021, Board of Trustees meetings.

The Diversity, Equity, Inclusion, and Anti-Racism Committee (DEIAR) announced the individuals selected to become the inaugural Vice Chiefs for Diversity, Equity, and Inclusion (VCDEI) for each division within the department of medicine. These individuals are all wonderful thoughtful leaders who have shown a commitment to improving DEI within the department.